PO-0086 Clinical Utility Of The Conjugated Linoleic Acid As Adyuvant On Overweight And Obesity Treatment In Child And Adolescent

Background and aims Obesity as a universal public health problem requires precise measuresto limit its impact on the population. Antiobesity drugs have been used in adults andadolescents. The use of nutritional aids isnoted in the literature as a treatment option for obesity. Conjugated linoleic acid (CLA) has beenused in general population including children, causing a reduction in weight, body mass index (BMI) and waist circumference (WC) after administration for 12 to 104 weeks. The objective was to determine theusefulness of CLA added to the lifestyle intervention, reflected insomatometric parameters in a group of children and adolescents with obesity. Methods 21 children and adolescents with overweight andobesity, used CLA during 12 weeks and then only lifestyle up to 32 weeks. They were cited every 4 weeks to measurement of weight, height, BMI, WC, waistheight index (WHI) and blood pressure. Results All patients were monitoring 32 weeks, 14 attended 100%of the appointments. There was a continuous decrease of the WHI and BMI even afterCLA was suspended, attributing this effect to continued lifestyle intervention, despite a BMI rebound at week 16. Conclusions The use of CLA may be useful as adjuvant during lifestyleintervention (diet and physical activity) in obese children and adolescents.